On November 21st, Artefact organized the international Summit AI for Health where we welcomed 2000+ participants, that brought together:

• 145+ high-level speakers from the major actors of the Pharma and Health sector made us the honour of sharing their return of experience: Pfizer, Servier, Biogen, Roche, Novo Nordisk, Takeda, AMGEN, Clariane, French Ministry of Digital Health, Healthcare Data Institute, EIT Health, PariSanté Campus, Resah, Unicancer.
   
• Our Technology Partners: Amazon Web Services, InstaDeep, IQVIA France, Microsoft, MyData-TRUST, Nebius, Pure Storage, Salesforce, Sqilline Health, Theodo HealthTech, TriNetX, VIDAL.

Leaders' POV: Accelerating drug innovation through AI | Dr. Claude Bertrand, Executive Vice-President R&D at Servier, Virginie Dominguez, Executive Vice-President Digital, Data & IT at Servier, and Paul de Balincourt, Partner - Healthcare Data & AI Transformation at Artefact

Artificial Intelligence: On a mission to make drug development faster and smarter | Reda Guiha, Country President France at Pfizer, and Damien Gromier, CEO & Founder of AI for Health at Artefact

Strategic vision for rare diseases | Prof. Anita Burgun, Associate Researcher at Institute Imagine, Thibaud Guymard, Head of Innovation, Services & Digital at Biogen, Solange Roumengous, Head of Industrial Partnerships at the French National Database of Rare Diseases, Corinne Blachier Poisson, President France at AMGEN, François Macary, Semantic interoperability expert at Use & Share, and Virginie Lasserre, External Affairs Director at Johnson & Johnson

Omni-channel engagement of HCPs in the Age of GenAI | Patrice Haton, Strategic Solution Engineer, Leader HLS France at Salesforce, Gaëlle Boterf, Director, Industry Advisor - Healthcare & Life Sciences EMEA at Salesforce, Dr. Grégoire Pigné, CEO & Co-founder of PulseLife, Florent Hassen, Global Product Owner - Customer Engagement Suite at Roche, and Marine Sortais, Consulting Director at Artefact

The Generative AI revolution for drug discovery | Yann Gaston-Mathé, CEO & Founder at Iktos, Alex Merwin, Head of Growth, Healthcare & Life Sciences Startups at AWS, Samantha Jerusalmy, Partner at Elaia, Hervé Minoux, Head of AI for Large Molecule Research at Sanofi, and Sandrine Cochard, Editorial Director at Mind Group

Preventing frailty and AI-geing well | Anne-Charlotte Dymny, Chief Information & Digital Officer at Clariane, Adeline Martin, Project Coordinator at CNES MEDES, and Thomas Filaire, Partner at Artefact

Unleashing the power of AI in Clinical Trials: Key Insights from PFIZER & ARTEFACT | Luca Mollo, Vice President, Medical Director France, M.D. at Pfizer, Thomas Filaire, Partner at Artefact, and Léa Giroulet, Senior Data Consultant at Artefact